Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.

Santiago Garcia; Larissa Stanberry; Christian Schmidt; Scott Sharkey; Michael Megaly; Mazen S Albaghdadi; Perwaiz M Meraj; Ross Garberich; Farouc A Jaffer; Ada C Stefanescu Schmidt; Simon R Dixon; Jeffrey J Rade; Timothy Smith; Mark Tannenbaum; Jenny Chambers; Frank Aguirre; Paul P Huang; Dharam J Kumbhani; Thomas Koshy; Dmitriy N Feldman; Jay Giri; Prashant Kaul; Craig Thompson; Houman Khalili; Brij Maini; Keshav R Nayak; Mauricio G Cohen; Sripal Bangalore; Binita Shah; Timothy D Henry

Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.

Santiago Garcia
, Larissa Stanberry
, Christian Schmidt
, Scott Sharkey
, Michael Megaly
, Mazen S Albaghdadi
, Perwaiz M Meraj
, Ross Garberich
, Farouc A Jaffer
, Ada C Stefanescu Schmidt
, Simon R Dixon
, Jeffrey J Rade
, Timothy Smith
, Mark Tannenbaum
, Jenny Chambers
, Frank Aguirre
, Paul P Huang
, Dharam J Kumbhani
, Thomas Koshy
, Dmitriy N Feldman

Jay Giri, Prashant Kaul, Craig Thompson, Houman Khalili, Brij Maini, Keshav R Nayak, Mauricio G Cohen, Sripal Bangalore, Binita Shah, Timothy D Henry

Research output: Contribution to journal › Article

Abstract

OBJECTIVE: To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care.

BACKGROUND: We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data.

METHODS: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), and average door to balloon (D2B) times. Two periods, January 2019-February 2020 and March-April 2020, were defined to represent periods before (BC) and after (AC) initiation of pandemic mitigation measures, respectively. A generalized estimating equations approach was used to estimate the change in response variables at AC from BC.

RESULTS: Compared to BC, the AC period was characterized by a marked reduction in the number of activations for STEMI (29%, 95% CI:18-38, p

CONCLUSIONS: The COVID-19 Pandemic has adversely affected many aspects of STEMI care, including timely access to the cardiac catheterization laboratory for PPCI.

Original language	American English
Journal	Articles, Abstracts, and Reports
State	Published - Aug 7 2020

Access to Document

http://digitalcommons.providence.org/publications/3512

Cite this

Garcia, S., Stanberry, L., Schmidt, C., Sharkey, S., Megaly, M., Albaghdadi, M. S., Meraj, P. M., Garberich, R., Jaffer, F. A., Schmidt, A. C. S., Dixon, S. R., Rade, J. J., Smith, T., Tannenbaum, M., Chambers, J., Aguirre, F., Huang, P. P., Kumbhani, D. J., Koshy, T., ... Henry, T. D. (2020). Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Articles, Abstracts, and Reports. http://digitalcommons.providence.org/publications/3512

@article{f9a67480f38141d99a6cfb5d6be68f3b,

title = "Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.",

abstract = "OBJECTIVE: To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care. BACKGROUND: We previously reported a 38\% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data. METHODS: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), and average door to balloon (D2B) times. Two periods, January 2019-February 2020 and March-April 2020, were defined to represent periods before (BC) and after (AC) initiation of pandemic mitigation measures, respectively. A generalized estimating equations approach was used to estimate the change in response variables at AC from BC. RESULTS: Compared to BC, the AC period was characterized by a marked reduction in the number of activations for STEMI (29\%, 95\% CI:18-38, p CONCLUSIONS: The COVID-19 Pandemic has adversely affected many aspects of STEMI care, including timely access to the cardiac catheterization laboratory for PPCI.",

author = "Santiago Garcia and Larissa Stanberry and Christian Schmidt and Scott Sharkey and Michael Megaly and Albaghdadi, \{Mazen S\} and Meraj, \{Perwaiz M\} and Ross Garberich and Jaffer, \{Farouc A\} and Schmidt, \{Ada C Stefanescu\} and Dixon, \{Simon R\} and Rade, \{Jeffrey J\} and Timothy Smith and Mark Tannenbaum and Jenny Chambers and Frank Aguirre and Huang, \{Paul P\} and Kumbhani, \{Dharam J\} and Thomas Koshy and Feldman, \{Dmitriy N\} and Jay Giri and Prashant Kaul and Craig Thompson and Houman Khalili and Brij Maini and Nayak, \{Keshav R\} and Cohen, \{Mauricio G\} and Sripal Bangalore and Binita Shah and Henry, \{Timothy D\}",

year = "2020",

month = aug,

day = "7",

language = "American English",

journal = "Articles, Abstracts, and Reports",

}

Garcia, S, Stanberry, L, Schmidt, C, Sharkey, S, Megaly, M, Albaghdadi, MS, Meraj, PM, Garberich, R, Jaffer, FA, Schmidt, ACS, Dixon, SR, Rade, JJ, Smith, T, Tannenbaum, M, Chambers, J, Aguirre, F, Huang, PP, Kumbhani, DJ, Koshy, T, Feldman, DN, Giri, J, Kaul, P, Thompson, C, Khalili, H, Maini, B, Nayak, KR, Cohen, MG, Bangalore, S, Shah, B & Henry, TD 2020, 'Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.', Articles, Abstracts, and Reports. <http://digitalcommons.providence.org/publications/3512>

TY - JOUR

T1 - Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.

AU - Garcia, Santiago

AU - Stanberry, Larissa

AU - Schmidt, Christian

AU - Sharkey, Scott

AU - Megaly, Michael

AU - Albaghdadi, Mazen S

AU - Meraj, Perwaiz M

AU - Garberich, Ross

AU - Jaffer, Farouc A

AU - Schmidt, Ada C Stefanescu

AU - Dixon, Simon R

AU - Rade, Jeffrey J

AU - Smith, Timothy

AU - Tannenbaum, Mark

AU - Chambers, Jenny

AU - Aguirre, Frank

AU - Huang, Paul P

AU - Kumbhani, Dharam J

AU - Koshy, Thomas

AU - Feldman, Dmitriy N

AU - Giri, Jay

AU - Kaul, Prashant

AU - Thompson, Craig

AU - Khalili, Houman

AU - Maini, Brij

AU - Nayak, Keshav R

AU - Cohen, Mauricio G

AU - Bangalore, Sripal

AU - Shah, Binita

AU - Henry, Timothy D

PY - 2020/8/7

Y1 - 2020/8/7

N2 - OBJECTIVE: To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care. BACKGROUND: We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data. METHODS: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), and average door to balloon (D2B) times. Two periods, January 2019-February 2020 and March-April 2020, were defined to represent periods before (BC) and after (AC) initiation of pandemic mitigation measures, respectively. A generalized estimating equations approach was used to estimate the change in response variables at AC from BC. RESULTS: Compared to BC, the AC period was characterized by a marked reduction in the number of activations for STEMI (29%, 95% CI:18-38, p CONCLUSIONS: The COVID-19 Pandemic has adversely affected many aspects of STEMI care, including timely access to the cardiac catheterization laboratory for PPCI.

AB - OBJECTIVE: To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care. BACKGROUND: We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data. METHODS: Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations for STEMI, the number of activations leading to angiography and primary percutaneous coronary intervention (PPCI), and average door to balloon (D2B) times. Two periods, January 2019-February 2020 and March-April 2020, were defined to represent periods before (BC) and after (AC) initiation of pandemic mitigation measures, respectively. A generalized estimating equations approach was used to estimate the change in response variables at AC from BC. RESULTS: Compared to BC, the AC period was characterized by a marked reduction in the number of activations for STEMI (29%, 95% CI:18-38, p CONCLUSIONS: The COVID-19 Pandemic has adversely affected many aspects of STEMI care, including timely access to the cardiac catheterization laboratory for PPCI.

M3 - Article

JO - Articles, Abstracts, and Reports

JF - Articles, Abstracts, and Reports

ER -

Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.

Abstract

Access to Document

Fingerprint

Cite this